142 related articles for article (PubMed ID: 38809199)
1. Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer.
Dong B; Gu Y; Sun X; Wang X; Zhou Y; Rong Z; Zhang J; Shi X; Zhang Z; He X; Chen L; Xiong Q; Pang X; Cui Y
Adv Healthc Mater; 2024 May; ():e2400673. PubMed ID: 38809199
[TBL] [Abstract][Full Text] [Related]
2. Targeting anoikis resistance in prostate cancer metastasis.
Sakamoto S; Kyprianou N
Mol Aspects Med; 2010 Apr; 31(2):205-14. PubMed ID: 20153362
[TBL] [Abstract][Full Text] [Related]
3. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
4. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.
Zhang P; Song Y; Sun Y; Li X; Chen L; Yang L; Xing Y
FASEB J; 2018 Jul; 32(7):3924-3935. PubMed ID: 29505302
[TBL] [Abstract][Full Text] [Related]
5. The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.
Elshafae SM; Kohart NA; Altstadt LA; Dirksen WP; Rosol TJ
Prostate; 2017 May; 77(7):776-793. PubMed ID: 28181686
[TBL] [Abstract][Full Text] [Related]
6. Anoikis in phenotypic reprogramming of the prostate tumor microenvironment.
Nepali PR; Kyprianou N
Front Endocrinol (Lausanne); 2023; 14():1160267. PubMed ID: 37091854
[TBL] [Abstract][Full Text] [Related]
7. CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells.
Yu Y; Song Y; Cheng L; Chen L; Liu B; Lu D; Li X; Li Y; Lv F; Xing Y
J Exp Clin Cancer Res; 2022 Jun; 41(1):188. PubMed ID: 35655258
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
10. Anoikis molecular pathways and its role in cancer progression.
Paoli P; Giannoni E; Chiarugi P
Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918
[TBL] [Abstract][Full Text] [Related]
11. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.
Jia J; Zhang W; Liu JY; Chen G; Liu H; Zhong HY; Liu B; Cai Y; Zhang JL; Zhao YF
PLoS One; 2012; 7(12):e51549. PubMed ID: 23272116
[TBL] [Abstract][Full Text] [Related]
12. Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis?
Rennebeck G; Martelli M; Kyprianou N
Cancer Res; 2005 Dec; 65(24):11230-5. PubMed ID: 16357123
[TBL] [Abstract][Full Text] [Related]
13. Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.
Huang J; Lan X; Wang T; Lu H; Cao M; Yan S; Cui Y; Jia D; Cai L; Xing Y
Oncogene; 2020 Feb; 39(8):1739-1755. PubMed ID: 31740781
[TBL] [Abstract][Full Text] [Related]
14. Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK/ERK pathway.
Zhang P; Chen L; Song Y; Li X; Sun Y; Xiao Y; Xing Y
Exp Cell Res; 2016 Oct; 347(2):350-9. PubMed ID: 27569004
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.
Cagle P; Smith N; Adekoya TO; Li Y; Kim S; Rios-Colon L; Deep G; Niture S; Albanese C; Suy S; Collins SP; Kumar D
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34884984
[TBL] [Abstract][Full Text] [Related]
16. Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.
Begemann D; Anastos H; Kyprianou N
Int J Urol; 2018 Apr; 25(4):318-326. PubMed ID: 29345000
[TBL] [Abstract][Full Text] [Related]
17. NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway.
Sun X; Zhang Y; Xin S; Jin L; Cao Q; Wang H; Wang K; Liu X; Tang C; Li W; Li Z; Wen X; Yang G; Guo C; Liu Z; Ye L
Cancer Sci; 2024 Feb; 115(2):412-426. PubMed ID: 38115797
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
19. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
20. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis.
Khan SU; Fatima K; Malik F
Clin Exp Metastasis; 2022 Oct; 39(5):715-726. PubMed ID: 35829806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
